{"id":32722,"date":"2024-06-21T10:00:16","date_gmt":"2024-06-21T08:00:16","guid":{"rendered":"https:\/\/www.thema-med.com\/2024\/06\/21\/messico-prime-autorizzazioni-di-innovativi-software-as-a-medical-device-samd\/"},"modified":"2024-06-21T10:17:46","modified_gmt":"2024-06-21T08:17:46","slug":"messico-prime-autorizzazioni-di-innovativi-software-as-a-medical-device-samd","status":"publish","type":"post","link":"https:\/\/www.thema-med.com\/en\/2024\/06\/21\/messico-prime-autorizzazioni-di-innovativi-software-as-a-medical-device-samd\/","title":{"rendered":"MEXICO: First Authorisations of Innovative Software as a Medical Device (SaMD)"},"content":{"rendered":"<div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 fusion-flex-container nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start fusion-flex-content-wrap\" style=\"max-width:1144px;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_1 1_1 fusion-flex-column\" style=\"--awb-bg-size:cover;--awb-width-large:100%;--awb-margin-top-large:0px;--awb-spacing-right-large:1.92%;--awb-margin-bottom-large:0px;--awb-spacing-left-large:1.92%;--awb-width-medium:100%;--awb-spacing-right-medium:1.92%;--awb-spacing-left-medium:1.92%;--awb-width-small:100%;--awb-spacing-right-small:1.92%;--awb-spacing-left-small:1.92%;\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-text fusion-text-1\"><h2><strong>COFEPRIS<\/strong>, the Mexican regulatory authority, in May 2024 officially announced the <strong>approval of the first software as a<\/strong> <strong>SaMDmedical device<\/strong>, authorised through an <strong>equivalence procedure <\/strong>and in compliance with the requirements of the Regulation for Software as a Medical Device known as <strong>Appendix X<\/strong> of the 5.0 edition of the Supplement of Medical Devices of Pharmacopoeia <strong>(July 10, 2023)<\/strong>.<\/h2>\n<p><strong>High-tech software<\/strong> for the <strong>treatment of myocardial infarction<\/strong> is an innovative device that is being authorised in Mexico for the first time. The device consists of an interactive screen that receives, processes and transmits aortic and distal pressure signals in real-time, allowing healthcare professionals to customise treatments for effective care.<\/p>\n<p>The second authorised device, which can be used in a <strong>smartwatch<\/strong>, is intended for patients diagnosed with atrial fibrillation, to signal <strong>irregularities in heart rhythm<\/strong>. The instrument allows patients to receive real-time information on their heart rate and enables early identification of irregularities in heart rhythm.<\/p>\n<p><strong>Equivalence paths <\/strong><\/p>\n<p>The two software were approved through <strong>equivalence agreements<\/strong> with the US Food and Drug Administration (FDA).<\/p>\n<p>In the wake of the process of <strong>global harmonisation<\/strong> of regulations on medical devices, the Regulatory Authority of Mexico recognises and authorises with <strong>shortened procedures<\/strong> the entry of devices that have previous approval from regulatory authorities in other countries of the world, specifically: the United States, Canada, and Japan.<\/p>\n<p><strong>Regulation of Software as a Medical Device in Mexico<\/strong><\/p>\n<p>Software as a SaMD medical device found a new definition in July 2023, in Appendix X above.<\/p>\n<p>Whereas software was previously considered essentially as an accessory of a hardware device, in the <strong>new definition<\/strong> it is described more broadly and is suitable for the latest generation of devices.<\/p>\n<p>According to this definition, the device can be used for one or more medical purposes, without the need to be part of the hardware to fulfil the intended medical purpose. It can run on generic computer platforms and can be used alone and\/or in combination with other products. Mobile applications that meet this definition are considered software as a medical device. The software that powers the physical medical device is to be considered excluded from this definition.<\/p>\n<p><strong>Software as a Medical Device (SaMD)<\/strong> is classifiable according to risk <strong>Class I, II, or III<\/strong>; the classification criteria are set out in <strong>Rule 16<\/strong> of Appendix II of the 5.0 Edition Supplement of Medical Devices of the Pharmacopoeia.<\/p>\n<p><strong>Revisions<\/strong> in the classification rules for medical devices in Mexico are expected and updates will follow.<\/p>\n<p>&gt;&gt;&gt; To market medical devices in Mexico, including SaMDs, you can rely on Thema&#8217;s <a href=\"https:\/\/www.thema-med.com\/servizi-consulenza-strategico-regolatoria-aziende-dispositivi-medici-strumenti-medicali-dispositivi-medico-diagnostici-in-vitro\/registrazioni-internazionali-extra-ue-dispositivi-medici-dm-e-medico-diagnostici-in-vitro-ivd\/\">International Non-EU Registrations<\/a> and <a href=\"https:\/\/www.thema-med.com\/servizi-consulenza-strategico-regolatoria-aziende-dispositivi-medici-strumenti-medicali-dispositivi-medico-diagnostici-in-vitro\/local-representative-mercati-esteri\/\">Authorised Local Representative<\/a> services.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Source<\/strong>:<br \/>\n<a href=\"https:\/\/www.gob.mx\/cofepris\">Comisi\u00f3n Federal para la Protecci\u00f3n contra Riesgos Sanitarios | Gobierno | gob.mx (www.gob.mx)<\/a><\/p>\n<p><a href=\"https:\/\/www.gob.mx\/cofepris\/articulos\/cofepris-autoriza-primer-software-de-alta-tecnologia-para-tratamiento-de-infarto-al-miocardio\">Cofepris autoriza primer software de alta tecnolog\u00eda para tratamiento de infarto al miocardio | Comisi\u00f3n Federal para la Protecci\u00f3n contra Riesgos Sanitarios | Gobierno | gob.mx (www.gob.mx)<\/a><\/p>\n<p><a href=\"https:\/\/www.gob.mx\/cofepris\/articulos\/cofepris-aprueba-software-para-monitoreo-cardiaco-en-relojes-inteligentes?idiom=es\">Cofepris aprueba software para monitoreo card\u00edaco en relojes inteligentes | Comisi\u00f3n Federal para la Protecci\u00f3n contra Riesgos Sanitarios | Gobierno | gob.mx (www.gob.mx)<\/a><\/p>\n<p>&nbsp;<\/p>\n<\/div><\/div><\/div><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":115,"featured_media":32702,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-32722","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.0 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>MEXICO: First Authorisations of Innovative Software as a Medical Device (SaMD)<\/title>\n<meta name=\"description\" content=\"Il Medical Device Coordination Group (MDCG) ha aggiornato la linea guida MDCG 2024-2 Procedures for the updates of the European Medical Device Nomenclature\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.thema-med.com\/en\/2024\/06\/21\/messico-prime-autorizzazioni-di-innovativi-software-as-a-medical-device-samd\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MEXICO: First Authorisations of Innovative Software as a Medical Device (SaMD)\" \/>\n<meta property=\"og:description\" content=\"Il Medical Device Coordination Group (MDCG) ha aggiornato la linea guida MDCG 2024-2 Procedures for the updates of the European Medical Device Nomenclature\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.thema-med.com\/en\/2024\/06\/21\/messico-prime-autorizzazioni-di-innovativi-software-as-a-medical-device-samd\/\" \/>\n<meta property=\"og:site_name\" content=\"Thema Med\" \/>\n<meta property=\"article:published_time\" content=\"2024-06-21T08:00:16+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-06-21T08:17:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.thema-med.com\/wp-content\/uploads\/2024\/06\/MEX-.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1096\" \/>\n\t<meta property=\"og:image:height\" content=\"623\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"ufficiomarketing\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"ufficiomarketing\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.thema-med.com\/en\/2024\/06\/21\/messico-prime-autorizzazioni-di-innovativi-software-as-a-medical-device-samd\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.thema-med.com\/en\/2024\/06\/21\/messico-prime-autorizzazioni-di-innovativi-software-as-a-medical-device-samd\/\"},\"author\":{\"name\":\"ufficiomarketing\",\"@id\":\"https:\/\/www.thema-med.com\/en\/#\/schema\/person\/48e37298d13e3cf7f6d907af6a0d796d\"},\"headline\":\"MEXICO: First Authorisations of Innovative Software as a Medical Device (SaMD)\",\"datePublished\":\"2024-06-21T08:00:16+00:00\",\"dateModified\":\"2024-06-21T08:17:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.thema-med.com\/en\/2024\/06\/21\/messico-prime-autorizzazioni-di-innovativi-software-as-a-medical-device-samd\/\"},\"wordCount\":765,\"publisher\":{\"@id\":\"https:\/\/www.thema-med.com\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.thema-med.com\/en\/2024\/06\/21\/messico-prime-autorizzazioni-di-innovativi-software-as-a-medical-device-samd\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.thema-med.com\/wp-content\/uploads\/2024\/06\/MEX-.jpg\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.thema-med.com\/en\/2024\/06\/21\/messico-prime-autorizzazioni-di-innovativi-software-as-a-medical-device-samd\/\",\"url\":\"https:\/\/www.thema-med.com\/en\/2024\/06\/21\/messico-prime-autorizzazioni-di-innovativi-software-as-a-medical-device-samd\/\",\"name\":\"MEXICO: First Authorisations of Innovative Software as a Medical Device (SaMD)\",\"isPartOf\":{\"@id\":\"https:\/\/www.thema-med.com\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.thema-med.com\/en\/2024\/06\/21\/messico-prime-autorizzazioni-di-innovativi-software-as-a-medical-device-samd\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.thema-med.com\/en\/2024\/06\/21\/messico-prime-autorizzazioni-di-innovativi-software-as-a-medical-device-samd\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.thema-med.com\/wp-content\/uploads\/2024\/06\/MEX-.jpg\",\"datePublished\":\"2024-06-21T08:00:16+00:00\",\"dateModified\":\"2024-06-21T08:17:46+00:00\",\"description\":\"Il Medical Device Coordination Group (MDCG) ha aggiornato la linea guida MDCG 2024-2 Procedures for the updates of the European Medical Device Nomenclature\",\"breadcrumb\":{\"@id\":\"https:\/\/www.thema-med.com\/en\/2024\/06\/21\/messico-prime-autorizzazioni-di-innovativi-software-as-a-medical-device-samd\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.thema-med.com\/en\/2024\/06\/21\/messico-prime-autorizzazioni-di-innovativi-software-as-a-medical-device-samd\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.thema-med.com\/en\/2024\/06\/21\/messico-prime-autorizzazioni-di-innovativi-software-as-a-medical-device-samd\/#primaryimage\",\"url\":\"https:\/\/www.thema-med.com\/wp-content\/uploads\/2024\/06\/MEX-.jpg\",\"contentUrl\":\"https:\/\/www.thema-med.com\/wp-content\/uploads\/2024\/06\/MEX-.jpg\",\"width\":1096,\"height\":623},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.thema-med.com\/en\/2024\/06\/21\/messico-prime-autorizzazioni-di-innovativi-software-as-a-medical-device-samd\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.thema-med.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MEXICO: First Authorisations of Innovative Software as a Medical Device (SaMD)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.thema-med.com\/en\/#website\",\"url\":\"https:\/\/www.thema-med.com\/en\/\",\"name\":\"Thema Med\",\"description\":\"Quality and Regulatory Affairs for Medical Devices\",\"publisher\":{\"@id\":\"https:\/\/www.thema-med.com\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.thema-med.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":[\"Organization\",\"Place\"],\"@id\":\"https:\/\/www.thema-med.com\/en\/#organization\",\"name\":\"Thema\",\"alternateName\":\"Thema\",\"url\":\"https:\/\/www.thema-med.com\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.thema-med.com\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.thema-med.com\/wp-content\/uploads\/2022\/11\/logo-Themasrl-COLOR-hires-2440.png\",\"contentUrl\":\"https:\/\/www.thema-med.com\/wp-content\/uploads\/2022\/11\/logo-Themasrl-COLOR-hires-2440.png\",\"width\":2440,\"height\":2851,\"caption\":\"Thema\"},\"image\":{\"@id\":\"https:\/\/www.thema-med.com\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.linkedin.com\/company\/thema-s-r-l-\/\"],\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.thema-med.com\/en\/2024\/06\/21\/messico-prime-autorizzazioni-di-innovativi-software-as-a-medical-device-samd\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.thema-med.com\/en\/#\/schema\/person\/48e37298d13e3cf7f6d907af6a0d796d\",\"name\":\"ufficiomarketing\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.thema-med.com\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/61aa792ee358880e0c04a758e6f9078a28e175950ffc09fbeb595cd0ce2f89e2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/61aa792ee358880e0c04a758e6f9078a28e175950ffc09fbeb595cd0ce2f89e2?s=96&d=mm&r=g\",\"caption\":\"ufficiomarketing\"},\"url\":\"https:\/\/www.thema-med.com\/en\/author\/ufficiomarketing\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MEXICO: First Authorisations of Innovative Software as a Medical Device (SaMD)","description":"Il Medical Device Coordination Group (MDCG) ha aggiornato la linea guida MDCG 2024-2 Procedures for the updates of the European Medical Device Nomenclature","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.thema-med.com\/en\/2024\/06\/21\/messico-prime-autorizzazioni-di-innovativi-software-as-a-medical-device-samd\/","og_locale":"en_US","og_type":"article","og_title":"MEXICO: First Authorisations of Innovative Software as a Medical Device (SaMD)","og_description":"Il Medical Device Coordination Group (MDCG) ha aggiornato la linea guida MDCG 2024-2 Procedures for the updates of the European Medical Device Nomenclature","og_url":"https:\/\/www.thema-med.com\/en\/2024\/06\/21\/messico-prime-autorizzazioni-di-innovativi-software-as-a-medical-device-samd\/","og_site_name":"Thema Med","article_published_time":"2024-06-21T08:00:16+00:00","article_modified_time":"2024-06-21T08:17:46+00:00","og_image":[{"width":1096,"height":623,"url":"https:\/\/www.thema-med.com\/wp-content\/uploads\/2024\/06\/MEX-.jpg","type":"image\/jpeg"}],"author":"ufficiomarketing","twitter_card":"summary_large_image","twitter_misc":{"Written by":"ufficiomarketing","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.thema-med.com\/en\/2024\/06\/21\/messico-prime-autorizzazioni-di-innovativi-software-as-a-medical-device-samd\/#article","isPartOf":{"@id":"https:\/\/www.thema-med.com\/en\/2024\/06\/21\/messico-prime-autorizzazioni-di-innovativi-software-as-a-medical-device-samd\/"},"author":{"name":"ufficiomarketing","@id":"https:\/\/www.thema-med.com\/en\/#\/schema\/person\/48e37298d13e3cf7f6d907af6a0d796d"},"headline":"MEXICO: First Authorisations of Innovative Software as a Medical Device (SaMD)","datePublished":"2024-06-21T08:00:16+00:00","dateModified":"2024-06-21T08:17:46+00:00","mainEntityOfPage":{"@id":"https:\/\/www.thema-med.com\/en\/2024\/06\/21\/messico-prime-autorizzazioni-di-innovativi-software-as-a-medical-device-samd\/"},"wordCount":765,"publisher":{"@id":"https:\/\/www.thema-med.com\/en\/#organization"},"image":{"@id":"https:\/\/www.thema-med.com\/en\/2024\/06\/21\/messico-prime-autorizzazioni-di-innovativi-software-as-a-medical-device-samd\/#primaryimage"},"thumbnailUrl":"https:\/\/www.thema-med.com\/wp-content\/uploads\/2024\/06\/MEX-.jpg","articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.thema-med.com\/en\/2024\/06\/21\/messico-prime-autorizzazioni-di-innovativi-software-as-a-medical-device-samd\/","url":"https:\/\/www.thema-med.com\/en\/2024\/06\/21\/messico-prime-autorizzazioni-di-innovativi-software-as-a-medical-device-samd\/","name":"MEXICO: First Authorisations of Innovative Software as a Medical Device (SaMD)","isPartOf":{"@id":"https:\/\/www.thema-med.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.thema-med.com\/en\/2024\/06\/21\/messico-prime-autorizzazioni-di-innovativi-software-as-a-medical-device-samd\/#primaryimage"},"image":{"@id":"https:\/\/www.thema-med.com\/en\/2024\/06\/21\/messico-prime-autorizzazioni-di-innovativi-software-as-a-medical-device-samd\/#primaryimage"},"thumbnailUrl":"https:\/\/www.thema-med.com\/wp-content\/uploads\/2024\/06\/MEX-.jpg","datePublished":"2024-06-21T08:00:16+00:00","dateModified":"2024-06-21T08:17:46+00:00","description":"Il Medical Device Coordination Group (MDCG) ha aggiornato la linea guida MDCG 2024-2 Procedures for the updates of the European Medical Device Nomenclature","breadcrumb":{"@id":"https:\/\/www.thema-med.com\/en\/2024\/06\/21\/messico-prime-autorizzazioni-di-innovativi-software-as-a-medical-device-samd\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.thema-med.com\/en\/2024\/06\/21\/messico-prime-autorizzazioni-di-innovativi-software-as-a-medical-device-samd\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.thema-med.com\/en\/2024\/06\/21\/messico-prime-autorizzazioni-di-innovativi-software-as-a-medical-device-samd\/#primaryimage","url":"https:\/\/www.thema-med.com\/wp-content\/uploads\/2024\/06\/MEX-.jpg","contentUrl":"https:\/\/www.thema-med.com\/wp-content\/uploads\/2024\/06\/MEX-.jpg","width":1096,"height":623},{"@type":"BreadcrumbList","@id":"https:\/\/www.thema-med.com\/en\/2024\/06\/21\/messico-prime-autorizzazioni-di-innovativi-software-as-a-medical-device-samd\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.thema-med.com\/en\/"},{"@type":"ListItem","position":2,"name":"MEXICO: First Authorisations of Innovative Software as a Medical Device (SaMD)"}]},{"@type":"WebSite","@id":"https:\/\/www.thema-med.com\/en\/#website","url":"https:\/\/www.thema-med.com\/en\/","name":"Thema Med","description":"Quality and Regulatory Affairs for Medical Devices","publisher":{"@id":"https:\/\/www.thema-med.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.thema-med.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":["Organization","Place"],"@id":"https:\/\/www.thema-med.com\/en\/#organization","name":"Thema","alternateName":"Thema","url":"https:\/\/www.thema-med.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.thema-med.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.thema-med.com\/wp-content\/uploads\/2022\/11\/logo-Themasrl-COLOR-hires-2440.png","contentUrl":"https:\/\/www.thema-med.com\/wp-content\/uploads\/2022\/11\/logo-Themasrl-COLOR-hires-2440.png","width":2440,"height":2851,"caption":"Thema"},"image":{"@id":"https:\/\/www.thema-med.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/thema-s-r-l-\/"],"mainEntityOfPage":{"@id":"https:\/\/www.thema-med.com\/en\/2024\/06\/21\/messico-prime-autorizzazioni-di-innovativi-software-as-a-medical-device-samd\/"}},{"@type":"Person","@id":"https:\/\/www.thema-med.com\/en\/#\/schema\/person\/48e37298d13e3cf7f6d907af6a0d796d","name":"ufficiomarketing","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.thema-med.com\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/61aa792ee358880e0c04a758e6f9078a28e175950ffc09fbeb595cd0ce2f89e2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/61aa792ee358880e0c04a758e6f9078a28e175950ffc09fbeb595cd0ce2f89e2?s=96&d=mm&r=g","caption":"ufficiomarketing"},"url":"https:\/\/www.thema-med.com\/en\/author\/ufficiomarketing\/"}]}},"_links":{"self":[{"href":"https:\/\/www.thema-med.com\/en\/wp-json\/wp\/v2\/posts\/32722","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.thema-med.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.thema-med.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.thema-med.com\/en\/wp-json\/wp\/v2\/users\/115"}],"replies":[{"embeddable":true,"href":"https:\/\/www.thema-med.com\/en\/wp-json\/wp\/v2\/comments?post=32722"}],"version-history":[{"count":3,"href":"https:\/\/www.thema-med.com\/en\/wp-json\/wp\/v2\/posts\/32722\/revisions"}],"predecessor-version":[{"id":32725,"href":"https:\/\/www.thema-med.com\/en\/wp-json\/wp\/v2\/posts\/32722\/revisions\/32725"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.thema-med.com\/en\/wp-json\/wp\/v2\/media\/32702"}],"wp:attachment":[{"href":"https:\/\/www.thema-med.com\/en\/wp-json\/wp\/v2\/media?parent=32722"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.thema-med.com\/en\/wp-json\/wp\/v2\/categories?post=32722"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.thema-med.com\/en\/wp-json\/wp\/v2\/tags?post=32722"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}